SF 164 Minnesota Senate · 2025-2026 Regular Session

Public postsecondary institutions maintenance of a supply of opiate antagonists on system campuses requirement

This bill requires all public Minnesota colleges and universities to maintain a supply of naloxone (an opiate overdose reversal drug) on every campus building, with at least two doses of nasal naloxone available per building. It mandates that campus health staff and other designated personnel (like nurses and emergency responders) receive training to administer naloxone during overdose emergencies. The law also directs the state health department to provide training resources, such as videos, to help institutions implement the policy. The requirement takes effect for the 2025-2026 academic year.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 16, 2025 Last action Mar 6, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduction 1st Engrossment · 2 edits · Feb 24, 2025
MINOR
The bill text was updated from its introduction to its first engrossment version, reflecting amendments made during the legislative process. The most significant substantive change expands the requirement for nasal naloxone availability from all campus buildings to specifically 'campus residential buildings,' narrowing the scope of where this safety equipment must be kept. The language was also broadened to require a 'nasal opiate antagonist' rather than specifying 'naloxone,' allowing for other approved medications to be used.
Scope change
The requirement for naloxone availability is now limited to campus residential buildings instead of all campus buildings.
REQUIREMENT

The location requirement for nasal naloxone was narrowed from 'each campus building' to 'each campus residential building,' reducing the number of locations where the drug must be stocked.

The specific drug name was changed from 'nasal naloxone' to 'nasal opiate antagonist,' broadening the requirement to include other approved reversal agents beyond just naloxone.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
2
Committee
3
Mar 6, 2025
Upper · Passed
Comm report: To pass and re-referred to Higher Education
upper
Feb 24, 2025
Upper · Passed
Comm report: To pass as amended and re-refer to Health and Human Services
upper
Jan 16, 2025
Committee
Referred to Higher Education
upper
Jan 16, 2025
Introduced
Introduction and first reading
upper
1 primary · 3 co-sponsors

Sponsors